Related Experiment Video
Updated: Jun 9, 2026
07:12
Design of a Cyclic Pressure Bioreactor for the Ex Vivo Study of Aortic Heart Valves
Published on: August 23, 2011
Bioreactors for development of tissue engineered heart valves
Joel L Berry1, Julie A Steen, J Koudy Williams
1Department of Biomedical Engineering, University of Alabama at Birmingham, Birmingham, AL 35294, USA. jlberry@uab.edu
Annals of Biomedical Engineering
|September 8, 2010
Summary
Tissue engineered heart valves offer a promising alternative to traditional valve replacements, addressing limitations like durability and anticoagulation. Bioreactors are crucial for conditioning scaffolds and cells for these advanced heart valve therapies.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Regenerative Medicine
Background:
- Valvular heart disease affects millions globally, necessitating numerous valve replacement surgeries annually.
- Current prosthetic valves have significant drawbacks, including limited durability and risks associated with anticoagulation therapy.
- The need for improved heart valve substitutes with better hemodynamic performance and reduced complications is critical.
Purpose of the Study:
- To highlight the potential of tissue engineered heart valves (TEHVs) as a superior alternative to conventional prosthetic valves.
- To emphasize the indispensable role of bioreactors in the development and maturation of TEHVs.
- To outline the desired characteristics of an ideal heart valve substitute.
Main Methods:
- Discussion of the limitations of current valve replacement strategies.
- Exploration of the concept and development of tissue engineered heart valves.
- Emphasis on the function of bioreactors in TEHV development.
Main Results:
- TEHVs show promise in overcoming the shortcomings of current prosthetic valves.
- Bioreactors are essential for conditioning engineered tissues to mimic native valve function.
- The development of TEHVs aims to achieve normal hemodynamic performance and reduce adverse events.
Conclusions:
- Tissue engineered heart valves represent a significant advancement in cardiovascular repair.
- Bioreactors are a key technology enabling the successful development of functional TEHVs.
- Further research in TEHVs and bioreactor technology could revolutionize heart valve replacement therapy.
